Comparison of tumor markers in patients with squamous cell carcinoma of the head and neck

Acta Oto-Laryngologica, Supplement

Volumn , Issue 540, 1999, Pages 72-76

  Ogawa, Teruhiro ^a   Tsurusako, Yuuichi ^a   Kimura, Nobuhiko ^a   Nishioka, Shinji ^a   Akagi, Hirofumi ^a   Nishizaki, Kazunori ^a   Nishioka, Keiko ^b   Rutka, John ^c  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Takinomiya General Hospital   (Japan)

^c NONE

Author keywords

Carcinoembryonic antigen; Cyfra 21 1; Squamous cell carcinoma antigen

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER; ANTIGEN CYFRA21.1; KERATIN; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA RELATED ANTIGEN; SQUAMOUS CELL CARCINOMA-RELATED ANTIGEN; TUMOR ANTIGEN;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CANCER CLASSIFICATION; CLINICAL ARTICLE; DATA ANALYSIS; ENZYME IMMUNOASSAY; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; PATIENT SELECTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; BLOOD; COMPARATIVE STUDY; HEAD AND NECK TUMOR; MIDDLE AGED; RANDOMIZATION;

AGED; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINS; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; RANDOM ALLOCATION; SERPINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032588133     PISSN: 03655237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Niklinski J, Furman M, Chyczewski L, et al. Evaluation of Cyfra 21-1 as a new marker for non-small cell lung cancer. Eur J Cancer Prev 1994; 3: 227-30.
2. Stieber P, Hasholzer U, Bodenmuller H, et al. Cyfra 21-1: a new marker in lung cancer. Cancer 1993; 72: 707-13.
3. Doweck I, Barak M, Greenberg H, et al. Cyfra 21-1: a new potential marker for squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1995; 121: 177-81.
4. Ferdeghini M, Gadducci A, Annicchiarico C, et al. Serum Cyfra 21-1 assay in squamous cell carcinoma of the cervix. Arch Otolaryngol Head Neck Surg 1993; 13: 1841-4.
5. Goumas PD, Mastronikolis NS, Mastorakou AN, et al. Evaluation of TAT1 and Cyfra 21-1 in patients with head and neck squamous cell carcinoma. J Otorhinolaryngol 1997; 59: 106-14.
6. Szturmowicz M, Sakowicz A, Rudzinski P, et al. The clinical value of Cyfra 21-1 estimation for lung cancer patients. Int J Biol Markers 1996; 11: 172-7.
7. Morita T, Kikuchi T, Hashimoto S, et al. Cytokeratin-19 fragment (Cyfra 21-1) in bladder cancer. Eur Urol 1997; 32: 237-44.
8. Kurokawa H, Yamashita Y, Tokudome S, et al. Combination assay for tumor markers in oral squamous cell carcinoma. J Oral Maxillofac Surg 1997; 55: 964-6.